Philips Healthcare has acquired Xhale Assurance Inc. to add a novel pulse oximetry technology to complement its patient monitoring portfolio, which already offers the marketing-leading Rainbow SET pulse oximetry products from Masimo Corp.
Philips announced Aug. 29 that it bought Florida-based Xhale, developer of the SpO2 sensor, for an undisclosed sum. Xhale was founded in 2005 to develop the underlying sensor technology licensed...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?